home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Apsen Farmacêutica

SHARESHARESHARE
Present in Brazil for over 47 years, Apsen is a pharmaceutical 100% domestic industry, which provides healthcare solutions and welfare through research, innovation and availability of medicines excellence.
SHARESHARESHARE

RELATED NEWS


Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...
PRNEWSWIRE
READ MORE

A low-cost, easy-to-replicate test for tuberculosis might help developing nations better identify and treat the infectious and sometimes deadly disease, new research suggests. A study of the $2 test in rural Malawi in southeastern Africa found that it was reliable and could be easily employed in areas with a high incidence of tuberculosis, said study author Jesse Kwiek, an associate professor of microbiology at The Ohio State University.
The TB CX-test is designed to not only detect tuber...


READ MORE

Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that this would disrupt supplies of critical medicines. A motion on a no-deal Brexit is scheduled to be put before MPs at 2.30pm today, and a vote could take place any time after this. However, it’s expected that the vote is most likely to occur in the early evening as the debate over the motion is likely to be long and fierce. After MPs rejected Theresa May’s final attempt to g...

READ MORE

ViiV Healthcare has agreed to develop an investigational broadly neutralising antibody (bNAb) N6LS to treat and prevent human immunodeficiency virus 1 (HIV-1) infection. Founded in 2009 by GlaxoSmithKline (GSK) and Pfizer, ViiV focuses on developing therapies against HIV. Japanese pharmaceutical firm Shionogi also holds a stake in ViiV. The development of the bNAb candidate falls under an exclusive licensing agreement between GSK and the National Institutes of Health (NIH)’s National Insti...

READ MORE

Medical cannabis is available to certain patients across the UK for the first time from today. The groundbreaking decision was made so that people suffering from illnesses where other medicines have failed, have a way to treat their symptoms. It follows a campaign mounted in June after two boys with severe epilepsy were denied cannabis oil, sparking a Home Office review. This review resulted in certain medicinal cannabis-based products being classified as ‘schedule two’ – meani...

READ MORE

Novartis has announced the launch of an innovative technology-based healthcare program called SMS for Life 2.0 in Kaduna State, Nigeria. The program aims to increase the availability of essential medicines and improve care for patients across the region by using simple, available, and affordable technology. SMS for Life 2.0 is a joint public-private partnership led by Novartis and supported by its partners, the Kaduna State Ministry of Health and Vodacom...
WORLDPHARMANEWS.COM
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...